usstocks Kanghong Pharmaceutical

Source: Original Market Number of Securities Market Weekly Today\’s market conditions of this publication continue yesterday\’s steady counterattack style. However, the sector gain list has been replaced by a wave of \”new faces\”. However, today\’s capital flow is not without direction, and It focuses on blue-chip stocks during the intensive performance disclosure window period… Linyuan Investment, a well-known investment institution that has not been seen for a long time, also has new layout dynamics, and the underlying stock is also a blue-chip stock. li　Chemicals, pharmaceuticals, home furnishings, etc. lead the gains. Performance factors \”thread the needle\” Entering the overlapping and intensive disclosure window period of last year\’s annual report and this year\’s first quarter report, funds\’ attention to performance is entering a \”white-hot\” state. Some \”flaws\” of listed companies may be magnified by the market and vote with their feet. In contrast, the alpha of some blue-chip stocks may be driven up. On the surface, there is no obvious pattern in today\’s market, such as chemicals, medicine, real estate, household products, building materials, automobiles, etc., there are both resource stocks…